Stock Chart

LIVN

$74.70 -2.35%
Score: 55.0 HOLD
LEAPs: SELL $68
i
LEAPs Option Signal

Type: SELL growth_1yr
Strike: $68
Premium: $12.00
Expiry: Dec 18, 2026
Target: $70
Score: -76

LEAPs are long-term options (1+ year) with less time decay.
Pro
Screener
Vol: 1.15x (vs SPY: 1.1x | vs QQQ: 1.1x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Oct 01, 2026
Falling Wedge weak / forming — below our quality gate quality 57/100
A Falling Wedge is taking shape but hasn't passed our quality gate (60/100), so no projected path or levels are shown — only the forming rails on the chart below.
Historically breaks up 63% of the time; target hit in 75% of up-breaks (n=385)
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About LIVN - LivaNova PLC Ordinary Shares

UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the …

Key Statistics

Market Cap $4B
P/E Ratio 22.57

This LIVN stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track LIVN's price movements with trendlines, gamma walls, and key support/resistance levels.